{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:04:32Z","timestamp":1778749472487,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejphar.2007.01.072","type":"journal-article","created":{"date-parts":[[2007,2,9]],"date-time":"2007-02-09T07:05:52Z","timestamp":1171004752000},"page":"61-68","source":"Crossref","is-referenced-by-count":18,"title":["Raloxifene inhibits transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes"],"prefix":"10.1016","volume":"563","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Zhou","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-Wha","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Pak","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.01.072_bib1","first-page":"H301","article-title":"Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model","volume":"275","author":"Courtemanche","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0008-6363(99)00034-6","article-title":"Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model","volume":"42","author":"Courtemanche","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2007.01.072_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-2828(03)00007-5","article-title":"Effects of chromanol 293B on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes","volume":"35","author":"Du","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib4","first-page":"560","article-title":"Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells","volume":"254","author":"Dukes","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.01.072_bib5","first-page":"384","article-title":"Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes","volume":"281","author":"Feng","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.01.072_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/01.CIR.100.10.1095","article-title":"Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism","volume":"100","author":"Figtree","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.01.072_bib7","doi-asserted-by":"crossref","first-page":"257\u201326","DOI":"10.1016\/j.yjmcc.2003.11.003","article-title":"Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes","volume":"36","author":"Gao","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib8","first-page":"H463","article-title":"Comparative mechanisms of 4-aminopyridine-resistant Ito in human and rabbit atrial myocytes","volume":"269","author":"Li","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.RES.78.4.689","article-title":"Evidence for two components of delayed rectifier K+ current in human ventricular myocytes","volume":"78","author":"Li","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.01.072_bib10","first-page":"H369","article-title":"Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle","volume":"275","author":"Li","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib11","first-page":"H1270","article-title":"Biphasic effects of cell volume on excitation-contraction coupling in rabbit ventricular myocytes","volume":"282","author":"Li","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0705736","article-title":"Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current","volume":"142","author":"Liew","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/joe.0.1780417","article-title":"Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells","volume":"178","author":"Mori-Abe","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2006.06.049","article-title":"Characterisation of the relaxant response to raloxifene in porcine coronary arteries","volume":"545","author":"Moritz","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50\u00a0years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.01.072_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000016318","article-title":"Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity","volume":"9","author":"Nattel","year":"1999","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2007.01.072_bib17","first-page":"55","article-title":"Amelioration of ischemia-and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart","volume":"39","author":"Ogita","year":"2002","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00005344-200406000-00012","article-title":"Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: role of phosphatidylinositol 3-kinase\/Akt pathway","volume":"43","author":"Ogita","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.HYP.0000109320.25921.b1","article-title":"Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice","volume":"43","author":"Ogita","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2007.01.072_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2007.01.072_bib21","first-page":"H1773","article-title":"Contributions of a transient outward current to repolarization in human atrium","volume":"257","author":"Shibata","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib22","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.85.8.2966","article-title":"Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase","volume":"85","author":"Simoncini","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.01.072_bib23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/hc1102.105267","article-title":"Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene","volume":"105","author":"Simoncini","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.01.072_bib24","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1161\/01.STR.0000131479.08005.ca","article-title":"Raloxifene relaxes rat cerebral arteries in vitro and inhibits L-type voltage-sensitive Ca2+ channels","volume":"35","author":"Tsang","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2007.01.072_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1006\/jmcc.2000.1224","article-title":"Pharmacologic relevance of K(+) channel remodeling in atrial fibrillation","volume":"32","author":"Van Wagoner","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1006\/jmcc.2000.1147","article-title":"Molecular basis of electrical remodeling in atrial fibrillation","volume":"32","author":"Van Wagoner","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2007.01.072_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2007.01.072_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1463-1326.2002.00208.x","article-title":"Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women","volume":"4","author":"Wenger","year":"2002","journal-title":"Diabetes Obes. Metab."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T05:57:26Z","timestamp":1547013446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":28,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0014299907001367"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.072","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}